Your browser doesn't support javascript.
loading
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.
Dolladille, Charles; Ederhy, Stéphane; Sassier, Marion; Cautela, Jennifer; Thuny, Franck; Cohen, Ariel A; Fedrizzi, Sophie; Chrétien, Basile; Da-Silva, Angélique; Plane, Anne-Flore; Legallois, Damien; Milliez, Paul U; Lelong-Boulouard, Véronique; Alexandre, Joachim.
Afiliação
  • Dolladille C; Normandie University, University of Caen Normandy, Centre Hospitalier Universitaire (CHU) de Caen Normandie, PICARO Cardio-oncology Program, Department of Pharmacology, EA 4650, Signalisation, Électrophysiologie et Imagerie des Lésions d'Ischémie-Reperfusion Myocardique, Caen, France.
  • Ederhy S; Hôpitaux Universitaires Paris-Est, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Service de Cardiologie, Unico, Unité de Cardio-Oncologie APHP.6, GRC Groupe de Recherche Clinique en Cardio Oncologie, Inserm 856, Université Pierre et Marie Curie, Paris, France.
  • Sassier M; CHU de Caen Normandie, Department of Pharmacology, Caen, France.
  • Cautela J; Aix-Marseille Mediterranean University, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Thuny F; Cardio-Oncology Center, Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Hôpital Nord, Marseille, France.
  • Cohen AA; Centre de Recherche Cardiovasculaire et Nutrition, Inserm 1263, Inra, Marseille, France.
  • Fedrizzi S; Groupe Méditerranéen de Cardio-Oncologie, Marseille, France.
  • Chrétien B; Oncosafety Network of the Early Phases Cancer Trials Center, Marseille, France.
  • Da-Silva A; Aix-Marseille Mediterranean University, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Plane AF; Cardio-Oncology Center, Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Hôpital Nord, Marseille, France.
  • Legallois D; Centre de Recherche Cardiovasculaire et Nutrition, Inserm 1263, Inra, Marseille, France.
  • Milliez PU; Groupe Méditerranéen de Cardio-Oncologie, Marseille, France.
  • Lelong-Boulouard V; Oncosafety Network of the Early Phases Cancer Trials Center, Marseille, France.
  • Alexandre J; Hôpitaux Universitaires Paris-Est, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Service de Cardiologie, Unico, Unité de Cardio-Oncologie APHP.6, GRC Groupe de Recherche Clinique en Cardio Oncologie, Inserm 856, Université Pierre et Marie Curie, Paris, France.
JAMA Oncol ; 6(6): 865-871, 2020 06 01.
Article em En | MEDLINE | ID: mdl-32297899
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos